226 related articles for article (PubMed ID: 32380204)
1. A pH-responsive silica-metal-organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries.
Wang Y; Shahi PK; Xie R; Zhang H; Abdeen AA; Yodsanit N; Ma Z; Saha K; Pattnaik BR; Gong S
J Control Release; 2020 Aug; 324():194-203. PubMed ID: 32380204
[TBL] [Abstract][Full Text] [Related]
2. In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles.
Wang Y; Shahi PK; Wang X; Xie R; Zhao Y; Wu M; Roge S; Pattnaik BR; Gong S
J Control Release; 2021 Aug; 336():296-309. PubMed ID: 34174352
[TBL] [Abstract][Full Text] [Related]
3. Guanidinium-Rich Lipopeptide-Based Nanoparticle Enables Efficient Gene Editing in Skeletal Muscles.
Zhu M; Wang X; Xie R; Wang Y; Xu X; Burger J; Gong S
ACS Appl Mater Interfaces; 2023 Mar; 15(8):10464-10476. PubMed ID: 36800641
[TBL] [Abstract][Full Text] [Related]
4. Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework.
Alsaiari SK; Patil S; Alyami M; Alamoudi KO; Aleisa FA; Merzaban JS; Li M; Khashab NM
J Am Chem Soc; 2018 Jan; 140(1):143-146. PubMed ID: 29272114
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic-assisted biomineralization of CRISPR/Cas9 in near-infrared responsive metal-organic frameworks for programmable gene-editing.
Xu X; Liu C; Wang S; Mäkilä E; Wang J; Koivisto O; Zhou J; Rosenholm JM; Shu Y; Zhang H
Nanoscale; 2022 Nov; 14(42):15832-15844. PubMed ID: 36255392
[TBL] [Abstract][Full Text] [Related]
6. Biologically produced and metal-organic framework delivered dual-cut CRISPR/Cas9 system for efficient gene editing and sensitized cancer therapy.
Yu J; Tang M; Zhou Z; Wei Z; Wan F; Hou S; Li Q; Li Y; Tian L
Acta Biomater; 2024 Apr; 178():296-306. PubMed ID: 38417646
[TBL] [Abstract][Full Text] [Related]
7. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
[TBL] [Abstract][Full Text] [Related]
8. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
[TBL] [Abstract][Full Text] [Related]
9. Versatile Redox-Responsive Polyplexes for the Delivery of Plasmid DNA, Messenger RNA, and CRISPR-Cas9 Genome-Editing Machinery.
Wang Y; Ma B; Abdeen AA; Chen G; Xie R; Saha K; Gong S
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31915-31927. PubMed ID: 30222305
[TBL] [Abstract][Full Text] [Related]
10. Nanoscale ATP-Responsive Zeolitic Imidazole Framework-90 as a General Platform for Cytosolic Protein Delivery and Genome Editing.
Yang X; Tang Q; Jiang Y; Zhang M; Wang M; Mao L
J Am Chem Soc; 2019 Mar; 141(9):3782-3786. PubMed ID: 30722666
[TBL] [Abstract][Full Text] [Related]
11. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
12. Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery.
Noureddine A; Maestas-Olguin A; Saada EA; LaBauve AE; Agola JO; Baty KE; Howard T; Sabo JK; Espinoza CRS; Doudna JA; Schoeniger JS; Butler KS; Negrete OA; Brinker CJ; Serda RE
Acta Biomater; 2020 Sep; 114():358-368. PubMed ID: 32702530
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.
Zhang BC; Luo BY; Zou JJ; Wu PY; Jiang JL; Le JQ; Zhao RR; Chen L; Shao JW
ACS Appl Mater Interfaces; 2020 Dec; 12(51):57362-57372. PubMed ID: 33301289
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing.
Onuma H; Sato Y; Harashima H
J Control Release; 2023 Mar; 355():406-416. PubMed ID: 36773957
[TBL] [Abstract][Full Text] [Related]
15. Redox-Responsive Phase-Separating Peptide as a Universal Delivery Vehicle for CRISPR/Cas9 Genome Editing Machinery.
Sun Y; Xu X; Chen L; Chew WL; Ping Y; Miserez A
ACS Nano; 2023 Sep; 17(17):16597-16606. PubMed ID: 37584415
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct.
Kim S; Jeong YK; Cho CS; Lee S; Sohn CH; Kim JH; Jeong Y; Jo DH; Bae S; Lee H
Adv Healthc Mater; 2023 Feb; 12(4):e2201825. PubMed ID: 36326169
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
18. pH-Responsive Polymer Nanoparticles for Efficient Delivery of Cas9 Ribonucleoprotein With or Without Donor DNA.
Xie R; Wang X; Wang Y; Ye M; Zhao Y; Yandell BS; Gong S
Adv Mater; 2022 Jun; 34(23):e2110618. PubMed ID: 35119139
[TBL] [Abstract][Full Text] [Related]
19. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli-Responsive Vehicles.
Cai W; Luo T; Mao L; Wang M
Angew Chem Int Ed Engl; 2021 Apr; 60(16):8596-8606. PubMed ID: 32385892
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing.
Zhou W; Cui H; Ying L; Yu XF
Angew Chem Int Ed Engl; 2018 Aug; 57(32):10268-10272. PubMed ID: 29939484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]